From: Classification of patients with breast cancer according to Nottingham Prognostic Index highlights significant differences in immunohistochemical marker expression
Antibody
Clone
Source
Pretreatment
Dilution
ER
1D5
DAKO
pH 9.0
1:35
PR
636
1:50
HER-2
HercepTest
pH 6.1
Ready to use
Ki-67
MIB-1
1:100
p53
DO-7
1:1000
Bcl-2
124